E-GEOD-44353 - Identification of a prognostic gene expression-based signature for patients with prostate cancer treated with radical prostatectomy
Released on 1 April 2013, last updated on 8 April 2013
Gene expression profiling was performed on tissue samples via a complementary DNA-mediated annealing, selection, extension, and ligation (DASL) assay (Illumina). 1536 were selected for profiling. 210 prostate cancer samples were used.Random forests classifcation was applied to the DASL data, and a set of genes was selected for further development. Total RNA was isolated from prostate cancer prostatecomy samples, purified, cDNA generated, and DASL performed.
transcription profiling by array
Mark Erlander, Yi Zhang